IMRX
Immuneering Corp
4.10$
+1.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | -5.4% | +1.3% | -6.5% | +0.1% | -0.6% | +0.6% | -47.7% | -6.2% | +611.2% | -70.5% | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +17.9% | -5.5% | -4.9% | +5.6% | +31.5% | -22.5% | -8.9% | +4.0% | -14.3% | +114,185.0% | -99.9% | – | |
| – | +13.3% | -6.1% | +3.4% | -5.6% | -8.0% | +8.4% | +7.2% | +4.9% | +0.1% | +103,732.2% | -99.9% | – | |
| – | +15.7% | -4.9% | -2.7% | +2.4% | +20.4% | -15.8% | -4.7% | +4.2% | -14.6% | +15.3% | +25.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -21.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.